LifeStance Health Group, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| LifeStance Health Group, Inc. | ||
| Date: February 25, 2026 | By: | /s/ David Bourdon |
|---|---|---|
| David Bourdon | ||
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ David Bourdon | Chief Executive Officer and Director | February 25, 2026 |
| David Bourdon | (Principal Executive Officer) | |
| /s/ Ryan McGroarty | Chief Financial Officer and Treasurer | February 25, 2026 |
| Ryan McGroarty | (Principal Financial and Accounting Officer) | |
| /s/ Kenneth Burdick | Executive Chairperson of the Board of Directors | February 25, 2026 |
| Kenneth Burdick | ||
| /s/ Robert Bessler | Director | February 25, 2026 |
| Robert Bessler | ||
| /s/ Darren Black | Director | February 25, 2026 |
| Darren Black | ||
| /s/ Teresa DeLuca | Director | February 25, 2026 |
| Teresa DeLuca | ||
| /s/ Eric Palmer | Director | February 25, 2026 |
| Eric Palmer | ||
| /s/ Sarah Personette | Director | February 25, 2026 |
| Sarah Personette | ||
| /s/ Jeffrey Rhodes | Director | February 25, 2026 |
| Jeffrey Rhodes | ||
| /s/ Eric Shuey | Director | February 25, 2026 |
| Eric Shuey | ||
| /s/ Katherine Wood | Director | February 25, 2026 |
| Katherine Wood | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.